Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance
Charly Jehanno
,
Tamara Fernández-Calero
,
Denis Habauzit
,
Stéphane Avner
,
Frédéric Percevault
et al.
Journal articles
hal-02565572v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Jacques Galipeau
,
Mauro Krampera
,
Katarina Leblanc
,
Jan A Nolta
,
Donald G Phinney
et al.
Journal articles
hal-03229071v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions
Charly Jehanno
,
Frédéric Percevault
,
Noureddine Boujrad
,
Pascale Le Goff
,
Coralie Fontaine
et al.
Journal articles
hal-03221142v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Vitamin D as an early predictor of multiple sclerosis activity and progression.
Alberto Ascherio
,
Kassandra L. Munger
,
Rick White
,
Karl Köchert
,
Kelly Claire Simon
et al.
JAMA neurology , 2014, pp.306-14
Journal articles
inserm-01103094v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.
Perrine Janiaud
,
Cathrine Axfors
,
Janneke Van’t Hooft
,
Ramon Saccilotto
,
Arnav Agarwal
et al.
Journal articles
hal-03000824v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Cortical lesion detection using FLAWS in multiple sclerosis
J. Muller
,
R. Rahmanzadeh
,
C. Tsagkas
,
M. Barakovic
,
P. -J. Lu
et al.
Multiple Sclerosis Journal , 2021, 27 (2_SUPPL), pp.433-434
Journal articles
hal-03463740v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012)
Gilles Edan
,
Mark Freedman
,
Xavier Montalban
,
David Miller
,
Hans Hartung
et al.
Neurology , 2015, 84 (14 Supplement), pp.P7.012
Journal articles
hal-01259391v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Consensus-based guidance for conducting and reporting multi-analyst studies
Balazs Aczel
,
Barnabas Szaszi
,
Gustav Nilsonne
,
Olmo van den Akker
,
Casper Albers
et al.
Journal articles
inserm-03431812v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells.
Luc Sensebé
,
Karin Tarte
,
Jacques Galipeau
,
Mauro Krampera
,
Ivan Martin
et al.
Journal articles
inserm-00817456v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Predicting conversion to clinically definite multiple sclerosis using machine learning on the basis of cerebral grey matter segmentations
K. Bendfeldt
,
B. Taschler
,
L. Gaetano
,
P. Madoerin
,
P. Kuster
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.498--499
Journal articles
hal-01259385v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Vitamin D and the development and evolution of permanent black holes among patients with clinically isolated syndrome
K. C. Fitzgerald
,
K. Munger
,
M. S. Freedman
,
H. -P. Hartung
,
X. Montalban
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.399--400
Journal articles
hal-01259388v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11)
F. Foley
,
I. -K. Penner
,
Gilles Edan
,
M. S. Freedman
,
X. Montalban
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.249--251
Journal articles
hal-01259395v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
J Kuhle
,
M Hardmeier
,
G Disanto
,
K Gugleta
,
M Ecsedi
et al.
Journal articles
hal-01201949v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
7TH INTERIM ANALYSIS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) AND JOINT HEALTH IN PATIENTS WITH HEMOPHILIA A: AHEAD INTERNATIONAL
K. Khair
,
J. Oldenburg
,
D. A. Tsakiris
,
R. Klamroth
,
B. Guillet
et al.
Journal articles
hal-03162284v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
REAL WORLD BLEEDING RATES OVER 7 YEARS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN PATIENTS WITH HEMOPHILIA A AND TARGET JOINTS: AHEAD INTERNATIONAL
M. C. Ozelo
,
D. A. Tsakiris
,
R. Klamroth
,
B. Guillet
,
K. Khair
et al.
Haemophilia , 2021, 27 (S2), pp.112-113
Journal articles
hal-03162296v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The basal level of gene expression associated with chromatin loosening shapes Waddington landscapes and controls cell differentiation
Gilles Flouriot
,
Charly Jehanno
,
Yann Le Page
,
Pascale Le Goff
,
Benjamin Boutin
et al.
Journal articles
hal-02109253v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis
Jannis Müller
,
Francesco La Rosa
,
Jeremy Beaumont
,
Charidimos Tsagkas
,
Reza Rahmanzadeh
et al.
Journal articles
hal-03689749v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
Stéphanie Leroux
,
Valérie Biran
,
John van den Anker
,
Verena Gotta
,
Wei Zhao
et al.
Journal articles
hal-03216851v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING
J. Oldenburg
,
M. C. Ozelo
,
R. Klamroth
,
B. Guillet
,
A. Huth-Kuehne
et al.
Journal articles
hal-02501205v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The challenge of mapping the human connectome based on diffusion tractography
Klaus H Maier-Hein
,
Peter F. Neher
,
Christophe Houde
,
Marc-Alexandre Côté
,
Eleftherios Garyfallidis
et al.
Journal articles
hal-01631578v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges
Angelo Ghezzi
,
Maria Pia Amato
,
Gilles Edan
,
Hans-Peter Hartung
,
Eva Kubala Havrdová
et al.
Journal articles
hal-02887839v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11)
F. Barkhof
,
M. P. Wattjes
,
Gilles Edan
,
M. S. Freedman
,
X. Montalban
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.238--239
Journal articles
hal-01259398v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)
Mark S. Freedman
,
Ludwig Kappos
,
Gilles Edan
,
Xavier Montalban
,
Hans-Peter Hartung
et al.
Multiple Sclerosis Journal , 2016, 22, pp.19--20
Journal articles
hal-01300794v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Survey of diagnostic and treatment practices for multiple sclerosis in Europe
Óscar Fernández
,
M. Delvecchio
,
Gilles Edan
,
Sten Fredrikson
,
Gavin Giovannoni
et al.
Journal articles
inserm-01576518v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020
Viktoria Gloy
,
Andreas M Schmitt
,
Pascal Düblin
,
Julian Hirt
,
Cathrin Axfors
et al.
Journal articles
hal-04040824v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Aviv Ladanie
,
Andreas M Schmitt
,
Benjamin Speich
,
Florian Naudet
,
Arnav Agarwal
et al.
Journal articles
hal-03037506v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Kathryn C. Fitzgerald
,
Kassandra L. Munger
,
Hans-Peter Hartung
,
Mark S. Freedman
,
Xavier Montalbán
et al.
Journal articles
inserm-01576520v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Optical coherence tomography and ophthalmological findings in patients with CIS treated with interferon beta-1b: 11-year follow-up in BENEFIT (BENEFIT 11)
S. Lukas
,
J. V. M. Hanson
,
Gilles Edan
,
M. S. Freedman
,
X. Montalban
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.240--241
Journal articles
hal-01259384v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Role of Survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study
Romain Mathieu
,
Ilaria Lucca
,
Mihai Dorin Vartolomei
,
Aurélie Mbeutcha
,
Tobias Klatte
et al.
Journal articles
hal-01290421v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More